Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

This publication has 14 references indexed in Scilit:

• Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer
  Cancer, 1994
• Urokinase receptor and colorectal cancer survival
  The Lancet, 1994
• Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
  British Journal of Cancer, 1994
• Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
  Breast Cancer Research and Treatment, 1993
• Urokinase-type plasminogen activator and malignancy
  Fibrinolysis, 1993
• Prevention of metastasis by inhibition of the urokinase receptor.
  Proceedings of the National Academy of Sciences, 1993
• Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours
  British Journal of Cancer, 1991
• Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
  Fibrinolysis, 1990
• Binding of urokinase to specific receptor sites on human breast cancer membranes
  British Journal of Cancer, 1987
• Asymptotically Efficient Rank Invariant Test Procedures
  Journal of the Royal Statistical Society. Series A (General), 1972